PT1024824E - Composicao de vacina dispersivel solida para administracao oral - Google Patents

Composicao de vacina dispersivel solida para administracao oral

Info

Publication number
PT1024824E
PT1024824E PT98950200T PT98950200T PT1024824E PT 1024824 E PT1024824 E PT 1024824E PT 98950200 T PT98950200 T PT 98950200T PT 98950200 T PT98950200 T PT 98950200T PT 1024824 E PT1024824 E PT 1024824E
Authority
PT
Portugal
Prior art keywords
vaccine
composition
dispersival
solid
oral administration
Prior art date
Application number
PT98950200T
Other languages
English (en)
Portuguese (pt)
Inventor
Harry Seager
Original Assignee
Scherer Corp R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Corp R P filed Critical Scherer Corp R P
Publication of PT1024824E publication Critical patent/PT1024824E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
PT98950200T 1997-10-27 1998-10-27 Composicao de vacina dispersivel solida para administracao oral PT1024824E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722682.3A GB9722682D0 (en) 1997-10-27 1997-10-27 Pharmaceutical products

Publications (1)

Publication Number Publication Date
PT1024824E true PT1024824E (pt) 2004-11-30

Family

ID=10821162

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98950200T PT1024824E (pt) 1997-10-27 1998-10-27 Composicao de vacina dispersivel solida para administracao oral

Country Status (10)

Country Link
EP (1) EP1024824B1 (enExample)
JP (1) JP2001521007A (enExample)
AT (1) ATE274919T1 (enExample)
AU (1) AU9635998A (enExample)
DE (1) DE69826019T2 (enExample)
DK (1) DK1024824T3 (enExample)
ES (1) ES2227885T3 (enExample)
GB (1) GB9722682D0 (enExample)
PT (1) PT1024824E (enExample)
WO (1) WO1999021579A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
IL148247A0 (en) 1999-08-24 2002-09-12 Teva Pharma A vaccine composition and method of using the same
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
CA2516291C (en) * 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
US20060172005A1 (en) * 2003-07-10 2006-08-03 Kyowa Hakko Kogyo Co.,Ltd. Tablet and process for producing the same
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
AU2003287591C1 (en) 2003-11-10 2009-12-10 Serenity Pharmaceuticals Llc Pharmaceutical compositions including low dosages of desmopressin
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
EP2187926B1 (en) 2007-09-11 2012-01-25 Københavns Universitet Prevention of diabetes by administration of gliadin
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
CA2767673A1 (en) * 2009-07-17 2011-01-20 The Board Of Regents Of Oklahoma State University Supralingual vaccines and applicators
GB201009273D0 (en) * 2010-06-03 2010-07-21 Glaxosmithkline Biolog Sa Novel vaccine
JP6061859B2 (ja) * 2010-10-08 2017-01-18 アール．ピー． シェーラー テクノロジーズ エルエルシー デンプンを使用する経口ワクチン速溶性剤型
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物
US11523988B2 (en) * 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
WO1994020070A1 (en) * 1993-03-11 1994-09-15 Secretech, Inc. Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
US5709861A (en) * 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery

Also Published As

Publication number Publication date
AU9635998A (en) 1999-05-17
DE69826019T2 (de) 2005-09-15
ATE274919T1 (de) 2004-09-15
DE69826019D1 (de) 2004-10-07
EP1024824A1 (en) 2000-08-09
EP1024824B1 (en) 2004-09-01
WO1999021579A1 (en) 1999-05-06
DK1024824T3 (da) 2004-09-20
GB9722682D0 (en) 1997-12-24
JP2001521007A (ja) 2001-11-06
ES2227885T3 (es) 2005-04-01

Similar Documents

Publication Publication Date Title
PT1024824E (pt) Composicao de vacina dispersivel solida para administracao oral
NO20015073D0 (no) Vaksiner
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
ES2150493T3 (es) Adyuvantes para vacunas contra el virus sincitico respiratorio.
BR0114786A (pt) Composição imunogênica, método de tratamento de um paciente que sofre de, ou que é suscetìvel a, um câncer, e, uso de uma combinação de uma saponina, um oligotìdeo imunoestimulador e um antìgeno de câncer, e, método para a manufatura de uma composição
CY1118521T1 (el) Συνθεση εμβολιου και μεθοδος χρησης αυτου
NO970993L (no) Mutant enterotoksin som er effektiv som en ikke-toksisk oral adjuvant
ES2186809T3 (es) Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso.
GB0025577D0 (en) Vaccine
KR930702026A (ko) 자기항원의 경구 투여에 의한 자기면역 질병의 치료
ATE270707T1 (de) Entepneumovirus und entsprechendes impfstoff
MX9709870A (es) Uso de esporocistos u occistos para preparar una vacuna contra coccidiosis.
DK1259259T3 (da) Mucosal adjuvansformulering
EP1471936A4 (en) HIV VACCINE AND METHOD OF USE
SI1140168T1 (en) Vaccination against cancer
ATE182270T1 (de) Mukosale verabreichung von pneumokokken-antigenen
WO2001074396A8 (en) Composition and method for promoting oral health
AR023536A1 (es) Vacunas
ES2086536T3 (es) Uso de ketorolaco para el tratamiento de la enfermedad periodontal.
ES2102836T3 (es) El empleo de vacunas antihelminticas en el control de la enfermedad parasitaria asociada con la perdida de la inmunidad natural.
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
GT198500078A (es) Vacuna polivalente inmuno-estimulante
ECSP961797A (es) Vacunas que comprende un antigeno conjugado polisacarido
RU2002102522A (ru) Способ вакцинопрофилактики вирусных болезней телят